fda glp-1 enforcement news today takes aim at telehealth companies for promoting unofficial weight loss drug dupes An FDA advisory committee is

Nancy Rahnama, a Beverly Hills-based internal and bariatric medicine specialist with her own private practice, told local newspaper the Beverly Hills Courier.

A bit of consideration regarding the connection between GLP-1 medications and mental health is important, although theres no definitive evidence linking it to depression or suicide and the incidence rates are very minimal

H., Yockey, S

Discuss your current diabetes control if you have type 2 diabetes

Adapted from: Ast J, Novak AN et al

A healthcare provider can review benefits, submit documentation, and help determine whether an appeal may be appropriate if coverage is denied